Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash & Current Investments: 2016-2025

Historic Cash & Current Investments for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $68.1 million.

  • Organogenesis Holdings' Cash & Current Investments fell 28.25% to $68.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $399.6 million, marking a year-over-year increase of 5.42%. This contributed to the annual value of $136.2 million for FY2024, which is 30.49% up from last year.
  • Organogenesis Holdings' Cash & Current Investments amounted to $68.1 million in Q3 2025, which was down 13.08% from $78.4 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Cash & Current Investments peaked at $136.2 million during Q4 2024, and registered a low of $487,000 during Q3 2021.
  • Over the past 3 years, Organogenesis Holdings' median Cash & Current Investments value was $90.5 million (recorded in 2024), while the average stood at $96.0 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first spiked by 22,080.90% in 2022, then dropped by 28.25% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Cash & Current Investments (Quarterly) stood at $114.5 million in 2021, then declined by 9.81% to $103.3 million in 2022, then increased by 1.01% to $104.3 million in 2023, then spiked by 30.49% to $136.2 million in 2024, then decreased by 28.25% to $68.1 million in 2025.
  • Its last three reported values are $68.1 million in Q3 2025, $78.4 million for Q2 2025, and $117.0 million during Q1 2025.